Zosano Pharma Corp
NASDAQ:ZSAN
Zosano Pharma Corp
Cash from Operating Activities
Zosano Pharma Corp
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zosano Pharma Corp
NASDAQ:ZSAN
|
Cash from Operating Activities
-$28.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Zosano Pharma Corp's Cash from Operating Activities?
Cash from Operating Activities
-28.7m
USD
Based on the financial report for Mar 31, 2022, Zosano Pharma Corp's Cash from Operating Activities amounts to -28.7m USD.
What is Zosano Pharma Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-3%
Over the last year, the Cash from Operating Activities growth was 7%. The average annual Cash from Operating Activities growth rates for Zosano Pharma Corp have been 2% over the past three years , -3% over the past five years .